153 related articles for article (PubMed ID: 1440318)
1. [The optimization of the detection of tumors of the organs of the hepatobiliopancreatic area by a combination of the ultrasonic study method and of the determination of tumor markers in the blood serum].
Mit'kov VV; Briukhovetskiĭ IuA
Ter Arkh; 1992; 64(4):86-9. PubMed ID: 1440318
[TBL] [Abstract][Full Text] [Related]
2. [Tumor markers for pancreatic and biliary tract cancer].
Takezako Y; Okusaka T; Ueno H; Ikeda M; Morizane C; Najima M
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1443-6. PubMed ID: 15446574
[TBL] [Abstract][Full Text] [Related]
3. [Tumor markers in hepatoma, gallbladder-biliary tract and pancreas cancer].
Nakahara M; Fujisawa K
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3010-9. PubMed ID: 2445292
[TBL] [Abstract][Full Text] [Related]
4. [Comparison between scintigraphy and echography and the surgical findings in diseases of the hepatobiliopancreatic system].
Manolov G; Petkaneshkov A; Shanov G; Sazdova R; Velev G
Khirurgiia (Sofiia); 1985; 38(5):22-5. PubMed ID: 3910940
[No Abstract] [Full Text] [Related]
5. [Ultrasonic diagnosis of neoplasms of liver, biliary tract and pancreas].
Kitamura T
Nihon Rinsho; 1982; 40(1):71-8. PubMed ID: 7087207
[No Abstract] [Full Text] [Related]
6. Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma.
Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
Br J Cancer; 1992 May; 65(5):731-4. PubMed ID: 1316775
[TBL] [Abstract][Full Text] [Related]
7. [Laboratory diagnosis of tumors of the pancreato-biliary area in patients with mechanical jaundice].
Skvortsov SV; Lytsar' BN; Kalinin AV; Dolinskiĭ AG
Klin Med (Mosk); 1992; 70(5-6):21-3. PubMed ID: 1279265
[TBL] [Abstract][Full Text] [Related]
8. Multivariate analysis of six serum tumor markers (CEA, CA 50, CA 242, TPA, TPS, TATI) and conventional laboratory tests in the diagnosis of hepatopancreatobiliary malignancy.
Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
Anticancer Res; 1995; 15(6B):2731-7. PubMed ID: 8669855
[TBL] [Abstract][Full Text] [Related]
9. [Ultrasonic percutaneous imaging of neoplasms of liver, biliary tract and pancreas].
Tsuchiya Y; Nakano T; Tsunetomi S; Shinagawa T; Ukazi H; Unozawa T; Iino Y; Watanabe J; Morita M; Kimura K; Saisyo H; Ohto M; Ebara M; Karasawa E; Saotome N
Nihon Rinsho; 1982; 40(1):102-8. PubMed ID: 6283196
[No Abstract] [Full Text] [Related]
10. [Tumor markers in the diagnosis of tumors of the liver and biliary tract].
Marecek Z
Vnitr Lek; 1997 Mar; 43(3):167-70. PubMed ID: 9221578
[TBL] [Abstract][Full Text] [Related]
11. Gallbladder bile tumor marker quantification for detection of pancreato-biliary malignancies.
Brockmann J; Emparan C; Hernandez CA; Sulkowski U; Dietl KH; Menzel J; Wolters H; Glodny B; Senninger N
Anticancer Res; 2000; 20(6D):4941-7. PubMed ID: 11326643
[TBL] [Abstract][Full Text] [Related]
12. [The role of echography and computed tomography in distinguishing benign cystic neoplasms of the pancreas and biliary tract. A report of 3 cases].
Polverosi R; Sbeghen R; Zambelli C; Zanellato E; Sperti C
Radiol Med; 1994 Apr; 87(4):523-5. PubMed ID: 8190943
[No Abstract] [Full Text] [Related]
13. [Tumor markers in liver metastases of colorectal carcinoma].
Moreno Sierra J; Vincent E; Gea M; Ortega MD; Borque M; Madrigal J; Pimentel C; Represa J
Rev Esp Enferm Dig; 1990 Sep; 78(3):139-44. PubMed ID: 1980590
[TBL] [Abstract][Full Text] [Related]
14. High serum concentrations of sialyl Tn antigen in carcinomas of the biliary tract and pancreas.
Nanashima A; Yamaguchi H; Nakagoe T; Matsuo S; Sumida Y; Tsuji T; Sawai T; Yamaguchi E; Yasutake T; Ayabe H
J Hepatobiliary Pancreat Surg; 1999; 6(4):391-5. PubMed ID: 10664288
[TBL] [Abstract][Full Text] [Related]
15. [Early diagnostic system of minute hepatocellular carcinoma, and neoplasms of biliary tract and pancreas].
Okuda K; Tsuchiya Y; Saisho H
Nihon Rinsho; 1982; 40(1):146-50. PubMed ID: 6283199
[No Abstract] [Full Text] [Related]
16. [Ultrasonically guided percutaneous fine needle biopsy in the diagnosis of tumors of the liver, pancreas and biliary system].
Dong BW
Zhonghua Yi Xue Za Zhi; 1984 Jun; 64(6):348-50. PubMed ID: 6437633
[No Abstract] [Full Text] [Related]
17. [Role of carcinoembryonic antigen, carbohydrate antigen 19-9 and cytology of bile in diagnosis of biliary and pancreatic cancer].
Matsuda M; Shimizu Y; Chikamatsu E; Takayanagi K; Ishigure H; Murakami S; Odani K
Nihon Geka Gakkai Zasshi; 1991 Jun; 92(6):716-21. PubMed ID: 1886576
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma.
Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttila I
Anticancer Res; 1993; 13(5C):1883-7. PubMed ID: 8267397
[TBL] [Abstract][Full Text] [Related]
19. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer.
Ozkan H; Kaya M; Cengiz A
Hepatogastroenterology; 2003; 50(53):1669-74. PubMed ID: 14571813
[TBL] [Abstract][Full Text] [Related]
20. "Mass-forming" pancreatitis masquerades as pancreatic carcinoma.
Yamaguchi K; Chijiiwa K; Saiki S; Nakatsuka A; Tanaka M
Int J Pancreatol; 1996 Aug; 20(1):27-35. PubMed ID: 8872521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
